SURAKSHA
Start SIP
Invest Now
Start SIP in SURAKSHA
Performance
- Low
- ₹280
- High
- ₹288
- 52 Week Low
- ₹231
- 52 Week High
- ₹367
- Open Price₹280
- Previous Close₹285
- Volume10,802
- 50 DMA₹277.02
- 100 DMA₹286.73
- 200 DMA₹298.77
Investment Returns
- Over 1 Month + 3.38%
- Over 3 Month -11.74%
- Over 6 Month -3.38%
- Over 1 Year -9.92%
Smart Investing Starts Here Start SIP with Suraksha Diagnostic for Steady Growth!
Suraksha Diagnostic Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 44.7
- PEG Ratio
- 6.5
- Market Cap Cr
- 1,490
- P/B Ratio
- 6.5
- Average True Range
- 8.94
- EPS
- 6.13
- Dividend Yield
- 0
- MACD Signal
- -2
- RSI
- 63.25
- MFI
- 65.4
Suraksha Diagnostic Financials
Suraksha Diagnostic Technicals
EMA & SMA
Current Price
₹286.00
+
0.6
(0.21%)
- Bearish Moving Average 5
- Bullish Moving Average 11
- 20 Day
- ₹272.12
- 50 Day
- ₹277.02
- 100 Day
- ₹286.73
- 200 Day
- ₹298.77
Resistance and Support
284.77
- R3 296.93
- R2 292.47
- R1 289.23
- S1 281.53
- S2 277.07
- S3 273.83
Suraksha Diagnostic Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-05 | Quarterly Results | |
| 2025-11-10 | Quarterly Results | |
| 2025-08-08 | Quarterly Results | |
| 2025-05-28 | Audited Results & Final Dividend | |
| 2025-02-08 | Quarterly Results |
Suraksha Diagnostic F&O
About Suraksha Diagnostic
- NSE Symbol
- SURAKSHA
- BSE Symbol
- 544293
- Joint Managing Director & CEO
- Ms. Ritu Mittal
- ISIN
- INE877V01027
Similar Stocks to Suraksha Diagnostic
Suraksha Diagnostic FAQs
Suraksha Diagnostic share price is ₹286 As on 06 February, 2026 | 04:48
The Market Cap of Suraksha Diagnostic is ₹1489.5 Cr As on 06 February, 2026 | 04:48
The P/E ratio of Suraksha Diagnostic is 44.7 As on 06 February, 2026 | 04:48
The PB ratio of Suraksha Diagnostic is 6.5 As on 06 February, 2026 | 04:48
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.